SecurityGSK / GlaxoSmithKline plc
InstitutionAdviser Investments LLC
Shares3,100
Value $ 125,000
Related 377372AG2 / Glaxosmithkline Cap Inc. 0.70% 03/18/16
377372AH0 / Glaxosmithkline Cap Inc. 2.80% 03/18/23
377372AJ6 / Glaxosmithkline Cap Inc. 4.20% 03/18/43
377372AA5 / Glaxosmithkline Cap Inc Guaranteed Notes 4.375% 04/15/14
377372AB3 / Glaxosmithkline Cap Inc Guaranteed Notes 5.375% 04/15/34
377373AC9 / Glaxosmithkline Capital 1.50% 05/08/17
377373AD7 / Glaxosmithkline Capital 2.85% 05/08/22
377372AC1 / Glaxosmithkline Capital 4.85% Guaranteed Notes 5/15/13
377372AD9 / Glaxosmithkline Capital 5.65% Guaranteed Notes 5/15/18
377372AE7 / Glaxosmithkline Capital 6.375% Guaranteed Notes 5/15/38
377373AB1 / Glaxosmithkline Capital .75% 05/08/15

Adviser Investments LLC reports 3.33% increase in ownership of GSK / GlaxoSmithKline plc

August 02, 2018 - Adviser Investments LLC has filed a 13F-HR form disclosing ownership of 3,100 shares of GlaxoSmithKline plc (NYSE:GSK) with total holdings valued at $125,000 USD as of June 30, 2018. Adviser Investments LLC had filed a previous 13F-HR on May 14, 2018 disclosing 3,000 shares of GlaxoSmithKline plc at a value of $117,000 USD. This represents a change in shares of 3.33 percent and a change in value of 6.84 percent during the quarter.

Other investors with positions similar to Adviser Investments LLC include Baker Ellis Asset Management LLC, Norway Savings Bank, Proficio Capital Partners LLC, Ckw Financial Group, Security National Trust Co, and Duncker Streett & Co Inc.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 39.66 3,100 3.33 125 6.84 4 4 3.45
2018-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 3,000 117 117 0
2017-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 0 -100.00 0 -100.00 0 0
2017-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 13,074 531


CUSIP: 37733W105